BOSTON SCIENTIFIC CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
BOSTON SCIENTIFIC CORPORATION (BSX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 1.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 1.00%, a 66.67% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was 0.60%, a 50.00% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was 0.40%, a 0.00% change from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2022 was 0.40%, a 0.00% change from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | 1.00% 10-K · filed 2026-02-17 |
| 2024-12-31 | 0.60% 10-K · filed 2026-02-17 |
| 2023-12-31 | 0.40% 10-K · filed 2026-02-17 |
| 2022-12-31 | 0.40% 10-K · filed 2025-02-18 |
| 2021-12-31 | 0.40% 10-K · filed 2024-02-20 |
| 2020-12-31 | 64.40% 10-K · filed 2023-02-23 |
| 2019-12-31 | 3.60% 10-K · filed 2022-02-23 |
| 2018-12-31 | 0.80% 10-K · filed 2021-02-23 |
| 2009-12-31 | 0.50% 10-K · filed 2011-02-17 |
| 2008-12-31 | 0.50% 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |